Ledger.Open graph →
SEC Form D · filed May 2, 2016

Gemini Therapeutics, Inc

Offering
$2.0M
Sold
$2.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Carl L. Gordon · New York, NYDirectorJean M. George · Boston, MADirectorPatrick Enright · Trevose, PADirectorJames Mclaughlin · New York, NYExec · DirectorJason Rhodes · Cambridge, MADirectorEileen R. Digoia · Rye, NYDirectorJames Mclaughlin · New York, NYExec · DirectorJason Rhodes · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗